Stan V. Smith - 25 Apr 2024 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Stan V. Smith
Issuer symbol
MAIA
Transactions as of
25 Apr 2024
Net transactions value
+$632,741
Form type
4
Filing time
26 Apr 2024, 17:30:49 UTC
Previous filing
02 Apr 2024
Next filing
02 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MAIA Common Stock Purchase $299,409 +147,492 +17% $2.03 1,005,060 25 Apr 2024 See Footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Warrants Purchase $333,332 +147,492 $2.26 147,492 25 Apr 2024 Common Stock 147,492 $2.26 See Footnote F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock was purchased pursuant to a Securities Purchase Agreement dated April 22, 2024 and were issued under the Issuer's 2021 Equity Incentive Plan on April 25, 2024.
F2 These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
F3 The warrants were purchased pursuant to a Securities Purchase Agreement dated April 22, 2024 and were deemed options issued under the Issuer's 2021 Equity Inventive Plan on April 25, 2024. The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date.
F4 These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.